Previous Close | 23.99 |
Open | 24.08 |
Bid | 24.17 x 0 |
Ask | 24.19 x 0 |
Day's Range | 23.80 - 24.31 |
52 Week Range | 15.18 - 24.31 |
Volume | |
Avg. Volume | 1,814,222 |
Market Cap | 14.414B |
Beta (5Y Monthly) | 1.31 |
PE Ratio (TTM) | 9.25 |
EPS (TTM) | 2.61 |
Earnings Date | Feb 07, 2024 - Feb 12, 2024 |
Forward Dividend & Yield | 0.68 (2.82%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 26.56 |
Subscribe to Yahoo Finance Plus to view Fair Value for ARX.TO
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
(TSX: ARX) ARC Resources Ltd. ("ARC") confirms a quarterly eligible dividend amount of $0.17 per share for April 15, 2024 to shareholders of record on March 28, 2024. At March 15, 2024, the trailing 12-month payments to shareholders total $0.66 per share.
This is the campaign’s largest corporate gift and will support clinical trials and innovations in radiation oncologyCALGARY, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation, along with Alberta Health Services (AHS) and the University of Calgary (UCalgary), are thrilled to announce that ARC Resources Ltd. (ARC) has generously donated $5 million to the OWN.CANCER campaign. This donation is the largest corporate gift made to the campaign and will support clinical trials an